Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Pacific Biosciences of California Inc shares valued at $5,200 were sold by Farmer Michele on May 19 ’25. At $1.00 per share, Farmer Michele sold 5,195 shares. The insider’s holdings dropped to 269,259 shares worth approximately $0.32 million following the completion of this transaction.
Also, HENRY CHRISTIAN O sold 12,497 shares, netting a total of over 17,583 in proceeds. Following the sale of shares at $1.41 each, the insider now holds 2,225,357 shares.
Before that, Van Oene Mark had sold 6,486 shares from its account. In a trade valued at $9,126, the insider traded Pacific Biosciences of California Inc shares for $1.41 each. Upon closing the transaction, the insider’s holdings decreased to 6,486 shares, worth approximately $1.77 million.
As published in a research note from UBS on November 11, 2024, Pacific Biosciences of California Inc [PACB] has been rated down from a Buy to a Neutral. As of April 22, 2024, JP Morgan has decreased its “an Overweight” rating to a “Neutral” for PACB. Earlier on April 18, 2024, Goldman downgraded its rating. Their new recommendation was “a Neutral” for PACB stock which previously was a “a Buy”.
Analyzing PACB Stock Performance
On last trading session,, Pacific Biosciences of California Inc [NASDAQ: PACB] rose 1.72% to $1.18. The stock’s lowest price that day was $1.12, but it reached a high of $1.18 in the same session. During the last five days, there has been a surge of approximately 18.00%. Over the course of the year, Pacific Biosciences of California Inc shares have dropped approximately -35.52%.
Support And Resistance Levels for Pacific Biosciences of California Inc (PACB)
RSI (Relative Strength Index) is 57.34 on the 14-day chart, showing neutral technical sentiment.
Is Pacific Biosciences of California Inc subject to short interest?
Stocks of Pacific Biosciences of California Inc saw a sharp rise in short interest on 2025-05-30 jumping by 2.81 million shares to 52.02 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 49.21 million shares. A jump of 5.4% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 5.55 of the overall float, the days-to-cover ratio (short ratio) jumped to 5.55.
Which companies own the most shares of Pacific Biosciences of California Inc (PACB)?
In terms of Pacific Biosciences of California Inc share price expectations, FactSet research, analysts set an average price target of 3 in the next 12 months, up nearly 158.62% from the previous closing price of $1.16. Analysts anticipate Pacific Biosciences of California Inc stock to reach 4 by 2025, with the lowest price target being 2. In spite of this, 11 analysts ranked Pacific Biosciences of California Inc stock as Buy at the end of 2025. On December 14, 2023, Stephens assigned a price target of “an Overweight” to the stock and initiated coverage with a $11.
